29
Views
29
CrossRef citations to date
0
Altmetric
Research Article

A Major CYP2D6 Autoepitope in Autoimmune Hepatitis Type 2 and Chronic Hepatitis C is a Three-dimensional Structure Homologous to Other Cytochrome P450 Autoantigens

, , , , , , , , & show all
Pages 501-513 | Published online: 07 Jul 2009

  • Rizzetto, M., Swana, G. and Doniach, D. (1973) "Microsomal antibodies in active chronic hepatitis and other disorders". Clin. Exp. Immunol. 15, 331-344.
  • Homberg, J.C., Abuaf. N., Bernard, O. Islam, S., Alvarez, F., Khalil, S.H., Poupon, R., Darnis, F., Levy, V.G. and Grippon, P. (1987) "Chronic active hepatitis associated with antiliver/kidney microsome type 1 : a second type of 'autoimmune' hepatitis". Hepatology 7, 1333-1339.
  • Johnson, P.J. and McFarlane, I.G. (1993) "Meeting report: international autoimmune hepatitis group". Hepatology 18, 998-1005.
  • Zanger, U.M., Hauri, H.P., Loeper, J., Homberg, J.C. and Meyer, U.A. (1988) "Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type 2". Proc: Notl Acad. Sci. USA 85, 8256-8260.
  • Manns, M.P., Johnson, E.F., Griffin, K.J., Tan, E.M. and Sullivan, K.F. (1989) "Major antigen of liver kidney microsomal antibodies in idiopathic autoimmune hepatitis is cytochrome P450db1". J. Clin. Investig. 83, 1066-1072.
  • Guenguen, M., Yamamotoh, A.M., Bernard, O. and Alvarez, F. (1989) "Anti-liver kidney microsome antibody type 1 recognizes human cytochrome P450 db1", Biochem. Biophys. Res. Commun. 159, 542-547.
  • Eichelbaum, M. and Gross, A.S. (1990) "The genetic polymorphism of debrisoquine/sparteine metabolism-clinical aspects". Pharmacol. Ther. 46, 377-394.
  • Sachse, C. Brockmöller, J., Bauer, S. and Roots, I. (1997) "Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenolypic consequences". Am. J. Hum. Genet. 60, 284-295.
  • Conzalez, F.J., Skoda, R.C., Kimura, S., Umeno, M., Zanger, U.M., Neben, D.W., Gelboin, H.V., Hardwick, J.P. and Meyer, U.A. (1988) "Characterization of the common genetic defect in debrisoquine metabolism". Nature 331, 442-449.
  • Manns, M., Zanger, U., Gerken, G., Sullivan, K.F., Meyer zum Büschenfelde, K. and Eichelbaum, M. (1990) "Patients with type Il autoimmune hepatitis express functionally intact cytochrome P450 dbl that is inhibited by LKM1 autoantibodies in vitro but not in vivo". Hepatology 12, 127-132.
  • Jacz-Aigain, E., Laurent, J. and Alvarez, F. (1990) "Dextrometorphan phenotypes in paediatric patients with auoimmune hepatitis", Br. J. Pharmacol. 30, 153-154.
  • Guenguen, M., Boniface, O., Bernard, O., Clerc, F., Cartwright, T. and Alvarez, F. (1991 "Identification of the main epitope on human cytochrome P450IID6 recognized by anti-liver kidney microsome antibody", J. Autoimmun. 4, 607-615.
  • Manns, M.P. Griffin, K.J., Sullivan, K.F. and Johnson, E.F. (1991) "LKM-1 autoantibodies recognize a short linear sequence in P450IID6. a cytochrome P-450 monooxygenase". J. Clin. Investig88, 1370-1378.
  • Yamamoto, A.M., Cresteil, D., Boniface, O., Clerc, F.F. and Alvarez, F (1993) "Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM 1)". FMI: J. Immunol. 23, 1105-1111.
  • Yamamoto, A.M., Cresteil, D., Homberg, J.C. and Alvarez, F. (1993) "Characterization of anti-liver-kidney microsome antobody (anti-LKM1) from hepatitis C virus-positive and -negative sera", Gastroenterology 104, 1762-1767.
  • Klein, R., Zanger, U.M., Berg, T. Hopf, U. and Berg, P.A. (1999) "Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type Il and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes". Clin. Exp. Immunol. 118, 290-297.
  • Parez, N., Herzog, D., Jacqz-Aigrain, E., Homberg, J.C. and Alvarez, F. (1996) "Study of the B cell response to cytochrome P450IID6 in sera from chronic hepatitis C patients". Clin. Exp. Immunol. 106, 336-343.
  • Duclos-Vallee, J.C., Hajoui, O., Yamamoto, A.M., Jacqz-Aigrin, E. and Alvarez, F. (1995) "Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies". Gastroenterology 108, 470-476.
  • Strassburg, C.P and Manns, M.P (1995) "Autoimmune hepatitis versus viral hepatitis C". Liver 15, 225-232.
  • Lunel, F., Abuaf, N., Lionel, F., Grippon, P. Perrin, M., Coz, Y.L., Valla, D., Borotto, E., Yamamoto, A.M., Huraux, J.M., Opolon, P. and Homberg, J.C. (1992) "Liver/kidney microsome antibody type 1 and hepatitis C virus infection". Hepatolony 16(3), 630-636.
  • Abuaf, N., Lunel, F. Giral, P. Borotto, E., Laperche, S., Poupon, R., Opolon, P. Huraux, J.M. and Homberg, J.C. (1993) "Non-organ specific autoantibodies associated with chronic C virus hepatitis". J. Hepatol. 18, 359-364.
  • Czaja, A.J., Carpenter, H.A., Santrach, P.J. and Moore, S.B. (1995) "Immunologic features and HLA associations in chronic viral hepatitis". Gastroenteroloxy 108, 157-164.
  • Lindgren, S., Braun, H.B., Michel, G., Nemeth, A., Nilsson, S., Thome-Kromer, B. and Eriksson, S. (1997) "Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden. Swedish Internal Medicine Liver club". Scand, J. Gastroenterol. 32, 175-178.
  • Lohse, A.W., Gerkem, G., Mohr, H., Löhr, H.F., Treichel, U., Dienes, H.P. and Meyer Zum Büschenfelde, K.H. (1995) "Relation between autoimmune hepatitis and viral hepatitis: clinical and serological characteristics in 859 patients". Z. Gastwenterol. 33, 527-533.
  • Nishioka, M., Morshed, S.A., Kono, K., Himoto, T., Parveen, S., Arima, K., Watanabe, S. and Manns, M.P (1997) "Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C". J. Hepatol. 26, 992-1000.
  • Pawlotsky, J.M., Ben Yahia, M., Andre, C. Voisin, M-C., Intrator, L., Roudot-Thoraval, F., Deforges, L., Duvoux, C., Zafrani, E-L., Duval, J. and Dhumeaux, D. (1994) "Immunological disorders in C virus chronic active hepatitis: a prospective case-control study". Hepatolofiy 19, 841-848.
  • Reddy, K.R., Krawitt, E.L., Homberg, J.C., Jeffers, L.J., De Medina, M., Chastenay, B., Poupon, R., Opolon, P. Beaugrand, M. and Abuaf, N. (1995) "Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America". J. Viral Hepatol. 2, 175-179.
  • Di Bisceglie, A.M., Martin, P. Kassianides, C., Lisker-Melmam, M., Murray, L., Waggoner, J., Goodman, Z., Banks, S.M. and Hoofnagle, J.H. (1989) "Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo controlled trial". N. Engl. J. Med. 321, 1506-1510.
  • Davis, G.L., Balart, L.A., Schiff, E.R., Lindsay, K., Bodenheimer, H.C.J., Perillo, R.P. Carey, W., Jacobson, I.M., Payne, J., Dienstag, J.L., Van Thiel, D.H., Tamburro, C., Lefkovich, J., Albrecht, J., Meschievitz, C. Ortego, T.J., Gibas, A. and Group, H.I.T. (1989) "Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized controlled trial". N. Engl. J. Med. 321, 1501-1506.
  • Todros, L., Touscoz, G., D'Urso, N., Durazzo, M., Albano, E., PoIi, G., Baldi, M. and Rizzetto, M. (1991) "Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders", J. Hepatol, 13, 128-131.
  • Muratori, L., Lenzi, M., Cataleta, M., Giostra, F. and Ballardini, G. (1994) "Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C". J. Hepatol. 21, 199-203.
  • Dalekos, G.N., Wedemeyer, H., Obermayer-Straub, P. Kayser, A., Barm, A., Frank, H. and Manns, M.P (1999) "Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during a-interferon treatment". J. Hepatol. 30, 366-375.
  • Ma, Y. Peakman, M., Lobo-Yeo, A., Wen, L. Lenzi, M., Gaken, J., Farzaneh, F., Mieli-Vergani, G., Bianchi, F.B. and Vergani, D. (1994) "Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection". Clin. Exp. Immunol. 97, 94-99.
  • Muratori, L., Lenzi, M., Ma, Y. Cataleta, M., Mieli-Vergani, G., Vergani, D. and Bianchi, F.B. (1995) "Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease". Gut 37, 406-412.
  • Durazzo, M., Philipp, T. Van Pelt, F.N.A.M., Lüttig, B., Borghesio, E., Michel, G., Schmidt, E., Loges, S., Rizzetto, M. and Manns, M.P. (1995) "Heterogeneity of microsomal autoantibodies (LKM) in chronic hepatitis C and D virus infection". Gustroenterology 108, 455-462.
  • Yamamoto, A.M., Johanet, C., Duclos-Vallee, J.C., Bustarret, F.A., Alvarez, F., Homberg, J.C. and Bach, J.F. (1997) "A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay". Clin. Exp. Immunol. 108, 396-400.
  • Ma, Y., Thomas, M.G., Okamoto, M., Bogdanos, D.P., Nagl, S., Kerkar, N., Lopes, A.R., Muratori, L., Lenzi, M., Bianchi, F.B., Mieli-Vergani, G. and Vergani, D. (2002) "Key residues of a major cytochrome P4S02D6 epitope are located on the surface of the molecule" J Immunol. 169, 277-285.
  • Gillam, E.M.J., Guo, Z., Manin, M.V., Jenkins, C.M. and Guenguerich, P.P. (1995) "Expression of cytochrome P4SO 2D6 in E. coli, purification, and spectral and catalytic characterization", Arch. Biochem. Biophys. 319. 540-550.
  • Laemmli, U.K. (1970) "Cleavage of structural proteins during the assembly of the head of bacteriophage T4". Nature 222, 680-685.
  • Towbin, H.T., Staehelin. T. and Gordon, J. (1979) "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some application". Proc. Natl Acad. Sci. 76, 4350-434.
  • Sambrook, J., Fritsch, E.F., Maniatis, T., eds. (1989) Molecular Cloning. A Laboratory Manual. 2nd Ed. (Cold Spring Harbor Laboratory Press, New York).
  • Philipp, T., Durazzo, M., Trautwein, C., Alex, B., Sträub, P. Lamb, J.G., Johnson, E.F., Tukey, R.H. and Manns, M.P. (1994) "Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D". Lancer 344, 578-581.
  • Strassburg, C., Obermayer-Straub, P., Alex, B., Durazzo, M., Rizzetto, M., Tukey, R.H. and Manns, M.P. (1996) "Autantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis", Gastmentemlogy 11, 1582-1592.
  • Ma, Y. Gregorio, G., Gäken, J., Muratori, L., Bianchi, F.B., MieliVergani, G. and Vergani, D. (1997) "Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P450 2D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection", J. Hepatol. 26, 1396-1402.
  • Seelig, R., Renz, M., Bünger, G., Schröter, H. and Seelig, H.P. (1993) "Anti-LKM-1 antibodies determined by use of recombinant P4S02D6 in ELISA and Western Blot and their association with anti-HCV and HCV-RNA". Clin. Exp. Immunol. 92, 373-380.
  • Codoner-Franch, P., Paradis, K., Guenguen, M., Bernard, O., Costesec, A.A. and Alvarez, F. (1989) "A new antigen recognized by anti-liver-kidney-microsome antibody (LKMA)". Clin. Exp. Immunol. 75, 354-358.
  • Strassburg, C.P., Obermayer-Straub, P. and Manns, M.P. (1996) "Autoimmunity in hepatitis C and D virus infection". J. Viral. Hepat. 3, 49-59.
  • Modi, D., Paine, M.J., Sutcliffe, M.J., Lian, L-Y. Primrose, W.U., Wolf, C.R. and Roberts, G.C.K. (1996) "A model for cytochrome P4SO 2D6 based on homology modeling and NMR studies of substrate binding". Biochemistiy 35, 4540-4550.
  • Lecoeur, S., Andre, C. and Beaune, PH. (1996) "Tienilic acidinduced autoimmune hepatitis: anti-liver and -kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4S02C9". Mol. Pharmacol. 50, 326-333.
  • Beaune, P.H., Pessayre, D., Dansette, P. Mansuy, D. and Manns. M.P. (1994) "Autoantibodies against cytochromes P450: role in human diseases". Adv. Pharmacol. 30, 199-245.
  • Robin, M-A., Marat, M., Le Roy, M., Le Breton, F-P. Bonierbale, E., Dansette, P. Ballet, F., Mansuy, D. and Pessayre, D. (1996) "Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera", J. Clin. Investig. 98, 1471-1480.
  • Zimmerman, H.J., Lewis, J.H., Ishak, K.G. and Maddrey, W. (1984) "Ticrynafen-associated hepatic injury: analysis of 340 cases", Hepatology 4, 315-323.
  • Bourdi, M., Larrey, D., Nataf, J., Bernuau, J., Pessayre, D., Iwasaki, M., Guengerich, F.P. and Beaune, P.H. (1990) "Anti-liver endoplasmic reticulum antibodies are directed against human cytochrome P-4SOIA2. A specific marker of dihydralazine hepatitis", J. Clin. Investig. 85, 1967-1973.
  • Belloc, C. Gauffre, A., Andre, C. and Beaune, P.H. (1997) "Epitope mapping of human CYP1A2 in dihydralazine-induced autoimmune hepatitis". Pharmacogenetics 7, 181-186.
  • Leeder, J.S., Riley, R.J., Cook, V.A. and Spielberg, S.P (1992) "Human anti-cytochrome P4SO antibodies in aromatic anticonvulsant-induced hypersensitivity reactions". J. Pharmacol. Exp. Ther. 263, 360-367.
  • Gregorio, G.V., Portman, B., Reid, F. Donaldson, P.T., Doherty, D.G., McCartney, M., Vergani, D. and Mieli-Vergani, G. (1997) "Autoimmune hepatitis in childhood: a 20-year experience". Hepatology 25, 541-547.
  • Duchini, A., McHutchison, J.G. and Pockros, P.J. (2000) "LKMpositive autoimmune hepatitis in the western United States: a case series". Am. J. Gastroenterol. 95, 3238-3241.
  • Song, Y.H., Connor, E.L., Muir, A., She, J.X., Zovorich, B., Derovanesian, D. and Maclaren, N. (1994) "Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease". J. Clin. Endocrinol. Metabol. 78, 1108-1112.
  • Wedlock, N., Asawa, A., Baumann-Antczak, A., Rees Smith, B. and Furmaniak, J. (1993) "Autoimmune Addison's disease. Analysis of autoantiobody binding sites on human sterois 21-hydroxylase", FEBS 332, 123-126.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.